Cargando…
Uncovering the deubiquitinase activity landscape of breast cancer
Breast cancer is a highly heterogeneous disease with dynamic changes in the tumor microenvironment. Precision medicine will in the future provide the possibility to treat each individual cancer patient with the right (combination) therapy specifically tailored to personal needs. However, in order to...
Autores principales: | Liu, Sijia, ten Dijke, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781487/ https://www.ncbi.nlm.nih.gov/pubmed/33457450 http://dx.doi.org/10.18632/oncoscience.518 |
Ejemplares similares
-
Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer
por: Kim, Youngeun, et al.
Publicado: (2017) -
Deubiquitinase USP35 as a novel mitotic regulator via maintenance of Aurora B stability
por: Park, Jinyoung, et al.
Publicado: (2018) -
Deubiquitinases in cancer
por: Wei, Rongbin, et al.
Publicado: (2015) -
Targeting TGFβ signal transduction for cancer therapy
por: Liu, Sijia, et al.
Publicado: (2021) -
The New Genetic Landscape of Cushing’s Disease: Deubiquitinases in the Spotlight
por: Sbiera, Silviu, et al.
Publicado: (2019)